Structural Forces Impacting the Pharmaceutical Industry

A look at one biotech’s mission to map the immune system using artificial intelligence—and how its growth as a Big Pharma partner could help unlock the potential of next-generation cancer treatments.

The Jazz Pharmaceutical president and COO discusses her approach to the role and how it plays into the company’s overall goals.

Rafaat Rahmani, president and founder of Lifescience Dynamics, grew up in abject poverty, but such hardships—and a later violent brush with racism—would ultimately end up fueling a determined and entrepreneurial path in the life sciences.

Dr. Wagner discusses her work with the Bill and Melinda Gates Medical Research Institute.

The Calliditas Therapeutics CEO discusses her transition from a banker/investor to CEO of a pharma company.

Jan van de Winkel, PhD, president and CEO of Genmab, the longtime innovation engine in antibody drug development, discusses its vision for adding a new business identity: commercial driver.